Cuba will begin immunization against COVID-19 in pediatric population.
According to the study design, in the first stage, school-age minors from 12 to 18 years old will be included and then from 5 to 11 Cuba could soon begin immunization against Covid-19 in the pediatric population, between 5 and 18 years old, after requesting authorization from the country's drug regulatory entity, it was known on March 29.
According to the study design, in the first stage, school-age minors from 12 to 18 years old will be included and then from 5 to 11.
The vaccine candidates to be used will be Soberana 01 and Soberana 02, developed by the Finlay Institute of Vaccines (IFV) and that so far have proven security.
In April, the request for this study will be made to the Center for State Control of Medicines, Equipment and Medical Devices (Cecmed), the highest regulatory authority on the island.
Soberana 01 has demonstrated safety and for next April it will be requested to advance to phase II of clinical studies with this vaccine proposal. For its part, Soberana 02 advances in phase III of clinical trials, with 44 thousand 10 volunteers in eight municipalities of Havana and an intervention study that includes 150 thousand subjects from population sectors with high risk of infection and spread of the disease, of these, 74 thousand 665 health workers and the scientific pole.
The pediatric population will have the best anti-Covid-19 formulas developed in this country. Cuba also has three other vaccine candidates against the SARS-CoV-2 virus, which causes Covid-19: Soberana Plus (also from IFV), Mambisa, which is applied nasal, and Abdala, administered intravenously. -muscular, both developed by the Center for Genetic Engineering and Biotechnology.
The Caribbean nation accumulates a total of 8 651 infected with this coronavirus in pediatric age, of them 453 infants. To date, no death or reinfection of any child or adolescent has been recorded and 94 percent of those diagnosed are already on medical discharge; but they remain with the active virus 517.
Health authorities insist on the need to maintain hygienic-sanitary measures to contain the disease, and protect the little ones.
Competing interests: No competing interests